EP Patent

EP2101727B1 — Compositions for use to topically treat acne by administering a 19-nor containing vitamin d analog with or without a retinoid

Assigned to Wisconsin Alumni Research Foundation · Expires 2017-11-08 · 9y expired

What this patent protects

Patent listed against Dovonex.

Drugs covered by this patent

Patent Metadata

Patent number
EP2101727B1
Jurisdiction
EP
Classification
—
Expires
2017-11-08
Drug substance claim
No
Drug product claim
No
Assignee
Wisconsin Alumni Research Foundation
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.